Cormorant Asset Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-650,000
| Closed | -$21.2M | – | 118 |
|
|
2020
Q4 | $21.2M | Buy |
650,000
+150,000
| +30% | +$4.9M | 0.51% | 43 |
|
|
2020
Q3 | $15.3M | Sell |
500,000
-200,000
| -29% | -$6.13M | 0.59% | 42 |
|
|
2020
Q2 | $11.4M | Sell |
700,000
-100,000
| -13% | -$1.63M | 0.44% | 51 |
|
|
2020
Q1 | $7.96M | Sell |
800,000
-200,000
| -20% | -$1.99M | 0.37% | 48 |
|
|
2019
Q4 | $13.8M | Sell |
1,000,000
-231,500
| -19% | -$3.18M | 0.55% | 41 |
|
|
2019
Q3 | $18.7M | Sell |
1,231,500
-168,500
| -12% | -$2.56M | 1.14% | 26 |
|
|
2019
Q2 | $27.6M | Hold |
1,400,000
| – | – | 1.58% | 20 |
|
|
2019
Q1 | $23.2M | Buy |
1,400,000
+850,000
| +155% | +$14.1M | 1.57% | 23 |
|
|
2018
Q4 | $7.72M | Buy |
+550,000
| New | +$7.72M | 0.63% | 38 |
|